Literature DB >> 9405613

Thermodynamic stability of wild-type and mutant p53 core domain.

A N Bullock1, J Henckel, B S DeDecker, C M Johnson, P V Nikolova, M R Proctor, D P Lane, A R Fersht.   

Abstract

Some 50% of human cancers are associated with mutations in the core domain of the tumor suppressor p53. Many mutations are thought just to destabilize the protein. To assess this and the possibility of rescue, we have set up a system to analyze the stability of the core domain and its mutants. The use of differential scanning calorimetry or spectroscopy to measure its melting temperature leads to irreversible denaturation and aggregation and so is useful as only a qualitative guide to stability. There are excellent two-state denaturation curves on the addition of urea that may be analyzed quantitatively. One Zn2+ ion remains tightly bound in the holo-form of p53 throughout the denaturation curve. The stability of wild type is 6.0 kcal (1 kcal = 4.18 kJ)/mol at 25 degrees C and 9.8 kcal/mol at 10 degrees C. The oncogenic mutants R175H, C242S, R248Q, R249S, and R273H are destabilized by 3.0, 2.9, 1.9, 1.9, and 0.4 kcal/mol, respectively. Under certain denaturing conditions, the wild-type domain forms an aggregate that is relatively highly fluorescent at 340 nm on excitation at 280 nm. The destabilized mutants give this fluorescence under milder denaturation conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405613      PMCID: PMC24967          DOI: 10.1073/pnas.94.26.14338

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability.

Authors:  L Serrano; J T Kellis; P Cann; A Matouschek; A R Fersht
Journal:  J Mol Biol       Date:  1992-04-05       Impact factor: 5.469

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Contributions of the large hydrophobic amino acids to the stability of staphylococcal nuclease.

Authors:  D Shortle; W E Stites; A K Meeker
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

4.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

5.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

6.  A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.

Authors:  J Milner; A Cook; M Sheldon
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

7.  Determination and analysis of urea and guanidine hydrochloride denaturation curves.

Authors:  C N Pace
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

8.  Stability constant for the zinc-dithiothreitol complex.

Authors:  N W Cornell; K E Crivaro
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

9.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

10.  The use of 4-(2-pyridylazo)resorcinol in studies of zinc release from Escherichia coli aspartate transcarbamoylase.

Authors:  J B Hunt; S H Neece; A Ginsburg
Journal:  Anal Biochem       Date:  1985-04       Impact factor: 3.365

View more
  160 in total

1.  Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.

Authors:  P V Nikolova; K B Wong; B DeDecker; J Henckel; A R Fersht
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.

Authors:  Assaf Friedler; Lars O Hansson; Dmitry B Veprintsev; Stefan M V Freund; Thomas M Rippin; Penka V Nikolova; Mark R Proctor; Stefan Rüdiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.

Authors:  Stefan Rudiger; Stefan M V Freund; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

4.  Reversible aggregation plays a crucial role on the folding landscape of p53 core domain.

Authors:  Daniella Ishimaru; Luis M T R Lima; Lenize F Maia; Priscila M Lopez; Ana P Ano Bom; Ana P Valente; Jerson L Silva
Journal:  Biophys J       Date:  2004-08-06       Impact factor: 4.033

5.  Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.

Authors:  Caroline M S Ekblad; Assaf Friedler; Dmitry Veprintsev; Richard L Weinberg; Laura S Itzhaki
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

6.  Standards for immunohistochemical imaging: a protein reference device for biomarker quantitation.

Authors:  Donald H Atha; Upender Manne; William E Grizzle; Paul D Wagner; Sudhir Srivastava; Vytas Reipa
Journal:  J Histochem Cytochem       Date:  2010-08-30       Impact factor: 2.479

7.  p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells.

Authors:  Luciana P Rangel; Giulia D S Ferretti; Caroline L Costa; Sarah M M V Andrade; Renato S Carvalho; Danielly C F Costa; Jerson L Silva
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

8.  Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide.

Authors:  Natalia Issaeva; Assaf Friedler; Przemyslaw Bozko; Klas G Wiman; Alan R Fersht; Galina Selivanova
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

9.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Authors:  Ariele Viacava Follis; Fabien Llambi; Li Ou; Katherine Baran; Douglas R Green; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

10.  Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.

Authors:  Lei Ji; Jinjin Xu; Jian Liu; Ali Amjad; Kun Zhang; Qingwu Liu; Lei Zhou; Jianru Xiao; Xiaotao Li
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.